Rottenstein Law Group Relieved by FDA’s Decision to Heighten Sexual-Adverse-Event Warnings on Propecia and Proscar Labels

Share Article

The Rottenstein Law Group, which represents clients with claims stemming from adverse side effects caused by Propecia and Proscar, is heartened by the FDA’s April 12, 2012, expansion of Propecia’s and Proscar’s warning labels to include a broader range of adverse sexual events.

The Rottenstein Law Group, LLP

“Propecia labels will now include warnings for libido disorders, ejaculation disorders, and orgasm disorders that continued for men even months after stopping the drug,” according to CBS News. “Proscar's label will include a ‘decreased libido’ warning that continues after drug discontinuation. Both drugs' labels will also include a new description of reported cases of male infertility and poor semen quality that improved after patients stopped taking the drug.”

By including these disclosures, the new labels will forewarn potential Propecia and Proscar patients about the full extent of those drugs’ potential negative side effects—news that the Rottenstein Law Group has long been publicizing on its http:// Propecia Lawsuit Information Center. The Lawsuit Information Center web pages describe all of the issues Propecia and Proscar victims face and explain their options. It has features that allow for easy sharing, including links for automatic posting on Facebook and Twitter, specifically to enable visitors to spread the word about vaginal mesh implants and the dangers of vaginal mesh products.

The Rottenstein Law Group is a New York-based law firm that represents clients in prescription drug lawsuits. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective consumer products.

The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
1259 Veeder Drive
Hewlett NY 11557
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Rochelle Rottenstein, Esq.
Visit website